Company
Twi Pharms
Last checked: Nov 20, 2026Source: Drugs@FDA, ClinicalTrials.gov
NDAs and BLAs
6
4 still marketed
Novel approvals
1
Approvals since 2021
0
Originals and new uses
Phase 3 trials
0
Registered, any status
Trials by phase
All registered drug and biologic trials with this lead sponsor, any status. A public view of the pipeline.
Recent approvals
Originals and efficacy supplements, newest first.
- Forfivo Xl approved Nov 10, 2011
- Fluoxetine Hydrochloride approved Oct 6, 2011
- Zestril new use Jul 1, 2003
- Zestril new use Feb 7, 2000
Drugs in development (0)
Investigational drugs, not yet FDA-approved, in this company's active or recent Phase 2 and 3 trials. Phase 3 first.
No investigational drugs in Phase 2 or 3 trials under this sponsor name.
Recruiting Phase 3 trials
Largest first.
No recruiting Phase 3 trials under this sponsor name.
Marketed drugs (4)
Newest FDA action first.
- Forfivo Xl Bupropion Hydrochloride · 2011
- Naprelan Naproxen Sodium · 1996
- Tenormin Atenolol · 1981
- Zestril Lisinopril · 1988
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.